Prefequity invests in CaviTech Solutions

Lancashire-based CaviTech Solutions designs and manufactures complex high-precision injection moulds for the personal-care and medical sectors.

Formed in 1955, the company has continually invested in the latest technology and processes to build a strong market position in its chosen sectors. CaviTech’s highly automated manufacturing capability enables it to build repeatable series of interchangeable moulds that are delivered to market-leading customers around the world.

Prefequity has provided a long-term investment to CaviTech to repay its existing bank debt and to buy out minority shareholders.

Theo Dickens, Managing Partner at Prefequity, will join the board of CaviTech. He commented: “We are delighted with our investment in CaviTech. The company is led by a high-quality management team focused on delivering an exciting growth plan. This transaction showcases our philosophy of offering investors strong downside protection, coupled with the opportunity to generate attractive risk-adjusted returns through our equity ownership”.

Chris Smith, MD at CaviTech, added: “The Prefequity team delivered a flexible funding package that closely met our objectives and our timetable. We look forward to working together over the next few years as we continue to grow CaviTech and to take advantage of the significant global market opportunities we have identified.”